CheckMyRecalls

Meridian Bioscience Inc recalls Revogene C

Published
14 Jan 2026
Units affected
211 units
Agency
FDA
Country
United States

The hazard

The affected lots show a decline in performance over time, which may lead to false-negative results.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

Brand / company
Meridian Bioscience Inc
Codes / lots
UDI-DI: 00840733102349; Lot Numbers: 410300U195, 410300U196, 410300U197, 410300U201
Distribution
US Nationwide distribution and the OUS country of Italy.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.